296 related articles for article (PubMed ID: 32292113)
1. Stem Cell-Based Therapy for Coronavirus Disease 2019.
Zhao RC
Stem Cells Dev; 2020 Jun; 29(11):679-681. PubMed ID: 32292113
[TBL] [Abstract][Full Text] [Related]
2. Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential.
Khoury M; Rocco PRM; Phinney DG; Krampera M; Martin I; Viswanathan S; Nolta JA; LeBlanc K; Galipeau J; Weiss DJ
Cytotherapy; 2020 Nov; 22(11):602-605. PubMed ID: 32933835
[TBL] [Abstract][Full Text] [Related]
3. [Mesenchymal stem cells in therapy of coronavirus disease 2019 - a review].
Shi X; Yu L; Ding C
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1979-1991. PubMed ID: 33169564
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles from mesenchymal stem cells as a Covid-19 treatment.
O'Driscoll L
Drug Discov Today; 2020 Jul; 25(7):1124-1125. PubMed ID: 32387262
[No Abstract] [Full Text] [Related]
5. Potential application of mesenchymal stem cells and their exosomes in lung injury: an emerging therapeutic option for COVID-19 patients.
Al-Khawaga S; Abdelalim EM
Stem Cell Res Ther; 2020 Oct; 11(1):437. PubMed ID: 33059757
[TBL] [Abstract][Full Text] [Related]
6. Mesenchymal stem cell research progress for the treatment of COVID-19.
Yao D; Ye H; Huo Z; Wu L; Wei S
J Int Med Res; 2020 Sep; 48(9):300060520955063. PubMed ID: 32972277
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells: current clinical progress in ARDS and COVID-19.
Xiao K; Hou F; Huang X; Li B; Qian ZR; Xie L
Stem Cell Res Ther; 2020 Jul; 11(1):305. PubMed ID: 32698898
[TBL] [Abstract][Full Text] [Related]
8. [Mesenchymal stem cells in the treatment of COVID-19-progress and challenges].
Wang J; Zou W; Liu J
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):1970-1978. PubMed ID: 33169563
[TBL] [Abstract][Full Text] [Related]
9. Intravenous infusion of human umbilical cord Wharton's jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia.
Zhang Y; Ding J; Ren S; Wang W; Yang Y; Li S; Meng M; Wu T; Liu D; Tian S; Tian H; Chen S; Zhou C
Stem Cell Res Ther; 2020 May; 11(1):207. PubMed ID: 32460839
[TBL] [Abstract][Full Text] [Related]
10. Immunomodulation and Regeneration Properties of Dental Pulp Stem Cells: A Potential Therapy to Treat Coronavirus Disease 2019.
Zayed M; Iohara K
Cell Transplant; 2020; 29():963689720952089. PubMed ID: 32830527
[TBL] [Abstract][Full Text] [Related]
11. Expanded Mesenchymal Stem Cells: a novel therapeutic approach of SARS-CoV-2 pneumonia (COVID-19). Concepts regarding a first case in Spain.
Soler Rich R; Rius Tarruella J; Melgosa Camarero MT
Med Clin (Barc); 2020 Oct; 155(7):318-319. PubMed ID: 32753110
[No Abstract] [Full Text] [Related]
12. [Guide for the prevention and treatment of coronavirus disease 2019].
;
Zhonghua Jie He He Hu Xi Za Zhi; 2020 Jun; 43(6):473-489. PubMed ID: 32486556
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 and COVID-19: How much do we know?
Wang M; Liao Z
Acta Virol; 2020; 64(3):288-296. PubMed ID: 32985201
[TBL] [Abstract][Full Text] [Related]
14. COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not.
Akkoc T
Adv Exp Med Biol; 2020; 1298():167-176. PubMed ID: 32648245
[TBL] [Abstract][Full Text] [Related]
15. Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells.
Shu L; Niu C; Li R; Huang T; Wang Y; Huang M; Ji N; Zheng Y; Chen X; Shi L; Wu M; Deng K; Wei J; Wang X; Cao Y; Yan J; Feng G
Stem Cell Res Ther; 2020 Aug; 11(1):361. PubMed ID: 32811531
[TBL] [Abstract][Full Text] [Related]
16. Mesenchymal Stem Cell Therapy for COVID-19: Present or Future.
Golchin A; Seyedjafari E; Ardeshirylajimi A
Stem Cell Rev Rep; 2020 Jun; 16(3):427-433. PubMed ID: 32281052
[TBL] [Abstract][Full Text] [Related]
17. Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.
Rogers CJ; Harman RJ; Bunnell BA; Schreiber MA; Xiang C; Wang FS; Santidrian AF; Minev BR
J Transl Med; 2020 May; 18(1):203. PubMed ID: 32423449
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory effect of mesenchymal stem cells and mesenchymal stem-cell-derived exosomes for COVID-19 treatment.
Jayaramayya K; Mahalaxmi I; Subramaniam MD; Raj N; Dayem AA; Lim KM; Kim SJ; An JY; Lee Y; Choi Y; Raj A; Cho SG; Vellingiri B
BMB Rep; 2020 Aug; 53(8):400-412. PubMed ID: 32731913
[TBL] [Abstract][Full Text] [Related]
19. Current status of cell-based therapies for respiratory virus infections: applicability to COVID-19.
Khoury M; Cuenca J; Cruz FF; Figueroa FE; Rocco PRM; Weiss DJ
Eur Respir J; 2020 Jun; 55(6):. PubMed ID: 32265310
[TBL] [Abstract][Full Text] [Related]
20. The Novel Coronavirus: A Bird's Eye View.
Habibzadeh P; Stoneman EK
Int J Occup Environ Med; 2020 Apr; 11(2):65-71. PubMed ID: 32020915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
